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Abstract 
Introduction: Cardiac complications are a major cause of perioperative morbidity and mortality in patients 
undergoing colorectal cancer surgery. A quick and reliable system for predicting postoperative cardiac morbidity 
is needed to predict cardiac events in order to improve outcome in surgery. The aim of this study was to 
investigate the role of the biochemical marker NT-proBNP in the prediction of postoperative all-cause mortality, 
cardiac-related mortality and cardiovascular events in patients undergoing colorectal cancer resections.  
Methods: 100 consecutive patients undergoing colorectal cancer surgery were prospectively recruited.  Blood 
samples were taken preoperatively, 24h, 48h and 5-7 postoperative days to measure NT-proBNP levels. The 
predictive power of NT-proBNP levels was assessed using Receiver Operating Characteristics (ROC) curves.  
Results: Cardiac-related morbidity and mortality was 9%. Of eleven deaths, 5 were cardiac-related. 
Preoperative NT-proBNP was a good predictor of death with ROC area under curve (AUC) of 0.83 (95% C.I. 
0.673, 0.993) a strong predictor of cardiac death with AUC of 0.914 (95% C.I. 0.823, 1.000) and a good 
predictor of cardiac complications with AUC of 0.875 (95% C.I. 0.757, 0.993). NT-proBNP levels 24 hours and 
48 hours postoperatively were also strongly predictive of postoperative cardiac morbidity and mortality. 
Conclusion: Pre- and postoperative NT-proBNP have a role in predicting postoperative death and cardiac 
complications. This may have significant implications in the planning of postoperative care for high-risk patients. 
DOI : 10.14302/issn.2471-7061.jcrc-18-2446 
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Introduction 
 Cardiac complications are a major cause of 
perioperative morbidity and mortality in patients 
undergoing colorectal cancer surgery.1The prediction of 
these cardiac events is notoriously difficult, but 
essential, as determining the stage of heart disease may 
lead to different management choices, such as 
angiotensin converting enzyme inhibitors or b blockers2. 
These treatments can delay or reverse progression of 
disease and therefore may improve prognosis by 
reducing postoperative complications.  
 One important aim of preoperative evaluation is 
to identify patients with significant coronary artery 
disease who may be at risk of cardiac complications 
following surgery. Many studies have looked into factors 
that might adversely affect these cardiac events and 
they include increasing age, New York Heart Association 
class, left ventricular ejection fractions, diabetes mellitus 
and lower blood pressure.3 Some of these risk indices 
have been developed into preoperative cardiac risk 
scoring systems such as revised cardiac risk index 
(RCRI)4 and Goldman cardiac index.5 Other methods of 
assessing cardiac risks such as dobutamine cardiac 
stress testing and echocardiography are highly sensitive 
but are expensive and often limited by time and 
availability of resources. Furthermore, the Government 
has set a challenging target for the NHS, that by 
December 2008, no patient should wait more than 18 
weeks from the time of GP referral to the start of 
hospital treatment. These tests could potentially delay 
surgery and would therefore not be suitable for                    
pre-operative surgical patients. A quick and reliable 
system for predicting postoperative cardiac morbidity is 
needed to predict cardiac events in order to improve the 
outcome of surgery.  
 Recent published literature has indicated that 
Brain Natriuretic Peptide (BNP) and its related 
compound, N-terminal fragment pro B-type Natriuretic 
Peptide (NT-proBNP), can be used to identify patients at 
high risk of developing major adverse cardiac events 
following non-cardiac surgery.6 BNP is synthesized by 
human cardiac myocytes as a 108-amino acid                   
prohormone (proBNP), which is cleaved to the                      
32-residue BNP and the 76-residue NT-proBNP.7 Both 
BNP and NT-proBNP can be used as sensitive biomarkers 
of cardiac dysfunction7 and have been used as 
preoperative predictors of cardiac morbidity in cardiac8 
and non-cardiac surgery[6, 9, 10]. The biochemical 
markers BNP and NT-proBNP are available as   
commercial assays. 
 The aim of this study was to investigate the role 
of the biochemical marker NT-proBNP in the prediction 
of postoperative all-cause mortality, cardiac-related 
mortality and cardiovascular events in patients 
undergoing colorectal cancer resections.  
Methods 
 The study was approved by the regional ethics 
committee and hospital research and development 
department. Between September 2006 and October 
2007, 100 consecutive patients undergoing elective 
colorectal cancer resection who gave consent were 
recruited to the study.  All patients had preoperative 
cardiac risk stratification using the revised cardiac risk 
index, which stratifies patients into classes I – IV.4 Table 
1 shows the risk index variables and the risk of cardiac 
complications for respective classes. Serum                     
measurements were taken preoperatively and 
postoperatively at days 1, 2 and 5-7, for NT-proBNP and 
cardiac troponin-T (Tn-T). Clinical assessment and ECGs 
were also performed preoperatively and postoperatively 
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Characteristic Number of Patients 
Operation 
Right sided resection 
Anterior resection 
APR 
Left sided other 
Other 
42 
36 
5 
15 
2 
Postoperative histology 
A 
B 
C1 
C2 
Other 
13 
51 
23 
10 
3 
Table 2. Baseline Patient characteristics 
RCRI Class 
Number of                 
Patients 
Cardiac                                          
complications-survivors 
Cardiac deaths 
Other 
deaths 
I 
II 
III 
IV 
0 
76 
15 
9 
0 
4 
0 
0 
0 
2 
1 
2 
0 
3 
2 
1 
Table 3. The distribution of cardiac complications, cardiac deaths and other deaths according 
to risk stratification using the Revised Cardiac Risk Index (RCRI) 
Revised Cardiac Risk Index 
(RCRI) Class 
Number of variables 
Risk of Cardiac Complications 
(%) 
I 
II 
III 
IV 
0 
1 
2 
>2 
0.4 
0.9 
6.6 
11.0 
RCRI Variables: high-risk type of surgery, history of ischemic heart disease, history of congestive 
heart      failure, history of cerebrovascular disease, preoperative treatment with insulin, and pre-
operative serum creatinine >2.0 mg/dL 
Table 1. Cardiac risk in Non-cardiac surgery according to the revised cardiac risk index4 
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at days 1, 2 and 5-7. To avoid bias, all tests and clinical 
assessments were performed by a clinical researcher 
who was not involved in patients’ care.  
 Cardiac complications included acute myocardial 
infarction, silent myocardial infarction, acute coronary 
syndrome, heart failure and cardiac arrhythmias. The 
diagnosis of heart failure required a clinical diagnosis of 
heart failure and radiological evidence of pulmonary 
oedema. All ECGs were read by an experienced 
consultant cardiologist. Where cardiac complications 
were identified by the researcher, this was                
communicated to the clinical team looking after the 
patient for immediate referral to a cardiologist. 
 Data were also prospectively collected on type 
of resection undertaken, postoperative histology and 
postoperative complications. Surgery was carried out by 
one of four colorectal firms in all cases.  
Assay 
 Serum NT-proBNP levels were measured using a 
sandwich immunoassay principle utilising a biotinylated 
antibody; streptavidin-coated and streptavidin-coated 
microparticles, with electrochemical detection of the 
bound complex via the rare earth ruthenium. The 
normal NT-proBNP value using this assay is <40 pmol/L. 
Statistics 
 The value of preoperative NT-proBNP, 24 hours 
postoperative NT-proBNP and 48 hours postoperative     
NT-proBNP levels as predictors for overall death, cardiac 
death and cardiac complications were assessed using 
Receiver Operator Characteristic (ROC) curves.  The 
area under each ROC curve (i.e. AUC) was calculated. A 
perfect predictive score will be equal to one. A score 
showing good predictive value will have a value > 0.8. 
The sensitivities, specificities, negative predictive values 
(npv) and positive predictive values (ppv) were also 
calculated for NT-proBNP value cut-off levels of 40 pmol/
L and 90 pmol/L. 
Results 
 Of the 100 patients recruited, 66 were male and 
34 were female, with a median age of 72 years (range 
39-90). Table 2 shows the different types of colorectal 
operations performed along with their postoperative 
histology results.  
 
Adverse Outcomes 
 Of the 100 patients, there were 11                   
postoperative deaths, of which 5 were due to cardiac 
causes. These included 4 myocardial infarctions and one 
patient with acute left ventricular failure and atrial 
fibrillation. There were 9 patients with cardiac 
complications including the 5 cardiac-related deaths. 
 Table 3 shows the distribution of cardiac 
complications, cardiac deaths and other deaths 
according to risk stratification using the RCRI. Out of 76 
patients stratified to RCRI class II, there were 2 cardiac 
deaths, 3 non-cardiac deaths and 4 cardiac                          
complications (survivors). In this class of risk, this 
corresponded to a 7.9% (6/76) cardiac complication 
rate, compared with 0.9% predicted by the RCRI. 
 The causes of non-cardiac death (n=6) were 
pneumonia (n=2), MRSA sepsis from necrotic toe (n=1), 
Clostridium difficile sepsis (n=1), diarrhoea sepsis (n=1) 
and sepsis leading to MOF (n=1). 
Postoperative Tn-T 
 Tn-T levels were elevated in 11 patients within 1 
week postoperatively. Death from MI accounted for 4, 
there were 2 silent MI’s, 4 mild Tn elevations indicating 
minor myocardial injury (but not diagnostic of 
myocardial infarction) and 1 mild elevation from a 
patient who died from pneumonia leading to multiorgan 
failure. 
Preoperative NT-proBNP as a Predictor 
 For all-cause mortality, the ROC curve AUC was 
0.83 (95% c.i. 0.673, 0.993), making preoperative                 
NT-proBNP a good predictor of postoperative death 
(figure 1). For cardiac death, the AUC                                    
was 0.914 (95% c.i. 0.823, 1.000), making preoperative 
NT-proBNP a very strong predictor of postoperative 
cardiac death (figure 2). For cardiac complications 
(deaths and survivors) the AUC was 0.875 (95% c.i. 
0.757, 0.993), making preoperative NT-proBNP a good 
predictor of postoperative cardiac complications                               
(figure 3).  
Postoperative NT-proBNP as a Predictor 
 NT-proBNP values 24h post op were poorly 
predictive of death from all causes with AUC=0.754 
(95% c.i. 0.575, 0.934), but were good predictors of 
cardiac death and cardiac complications, with                     
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Figure 1. Pre-operative NT-proBNP as a                   
predictor of death 
Area under curve = 0.8330 with 95% c.i. 
(0.673, 0.993) 
Figure 2. Pre-operative NT-proBNP as a                      
predictor of cardiac death 
Area under curve = 0.914 with 95% c.i. (0.823, 
1.000) 
Figure 3. Pre-operative NT-proBNP as a predictor of 
cardiac complications 
Area under curve = 0. 875 with 95% c.i. (0.757, 
0.993) 
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AUC = 0.876 (95% c.i. 0.683, 1.000) and                         
0.840 (95% c.i. 0.659, 1.000) respectively.  
NT-proBNP values 48h post op, were not good 
predictors of death from all causes with AUC=0.748 
(95% c.i. 0.560, 0.936). However for prediction of 
cardiac mortality AUC was 0.907 (95% c.i. 0.807, 1.000) 
making it a strong predictor. For cardiac complications 
48h NT-proBNP levels were very strongly predictive 
(figure 9) with, AUC=0.939 (95% c.i. 0.878, 0.999). 
 Table 4 shows the sensitivity, specificity, ppv 
and npv of preoperative and postoperative NT-proBNP at 
predicting the outcomes. Generally, increasing the                            
cut-off value from 40 to 90 pmol/l increases the 
specificity of the test, but lowers the sensitivity. The 
tests had a high negative predictive value, but low 
positive predictive value. 
Discussion 
 Emerging data from published literature 
indicates that preoperative measurement of BNP and    
NT-proBNP is a good predictor for complications after 
cardiac surgery [8,11] and non-cardiac               
surgery.9 [12-14 ]Patients having both cardiac and 
vascular surgery have high rates of cardiac disease and 
the role of BNP as a predictor of postoperative events in 
high risk cardiac patients having non-cardiac surgery has 
previously been described.15 
 This study has demonstrated that both                    
pre-operative and postoperative measurement of                  
NT-proBNP can help in identifying patients at high risk of 
major adverse events following colorectal cancer 
surgery. Pre-operative NT-proBNP levels may be able to 
predict the pre-operative cardiac status of patients but 
do not necessary reflect the variable dynamic sequences 
of postoperative stress responses which may result in 
adverse cardiac events. On the other hand, the 
postoperative measurement of NT-proBNP takes these 
factors into consideration, particularly with respect to 
the risk of cardiac death or cardiac complications. 
 The use of NT-proBNP as a predictive                  
preoperative biochemical marker has significant potential 
clinical applications. It is envisaged that patients with 
high preoperative NT-proBNP levels, indicating a high 
risk of postoperative cardiovascular events, could be 
referred for cardiac optimisation. Valuable hospital 
resources, such as the use of intensive care monitoring, 
can also be targeted for patients who fall in this group. 
It remains to be seen whether such interventions would 
have any effect on patient morbidity or mortality. In our 
study, the greatest power of the preoperative                       
NT-proBNP value was as a negative predictor. This 
means that normal NT-proBNP values were associated 
with low risks of cardiac events. This seems to correlate 
with the results found in heart failure where the 
European Society of Cardiology Task force guidelines for 
the treatment of chronic heart failure state that 
natriuretic peptides “may be most useful clinically as a 
rule out test due to consistent and very high negative 
predictive values.”16 A potential application of this test 
would be to identify patients not requiring high 
dependency or intensive care post-operatively from the 
point of view of their cardiac function, if their                       
pre-operative NT-proBNP levels were less than 90pmol/l. 
 In our study, 11 patients (11%) had a rise in           
Tn-T post-operatively, 6 of which were not apparent 
clinically and 2 of which were diagnosed as silent 
myocardial infarctions. These 2 patients were referred to 
cardiologists and treated for myocardial infarction, with 
appropriate cardiology follow-up. The routine                    
measurement of post operative Tn-T, although useful for 
these 2 patients, may not be justified in the routine care 
of these patients when the cost of the test is considered. 
However, this has not been formally assessed in a               
cost-benefit analysis. Previous work on higher risk 
patients, undergoing elective and emergency aortic 
aneurysm repair, has yielded much higher proportions of 
patients having Tn-T rises postoperatively.17 There may 
be more justification in routine post operative Tn-T 
measurement in these patients. 
 The study has several limitations. Firstly, it was 
carried out in one centre, so it may not be possible to 
apply the results of this study to another population 
because of different prevalence of cardiac disease. 
Secondly data on confounding factors such as 
intraoperative blood loss and surgical contamination was 
not collected in this study. These could potentially 
heavily influence the outcome after surgery.                   
Remarkably, there were no anastomotic leaks diagnosed 
in this series of patients. It is possible  that some of 
these cardiac complications could be attributed to 
 Freely Available  Online 
www.openaccesspub.org  |  JCRC    CC-license             DOI : 10.14302/issn.2471-7061.jcrc-18-2446                    Vol-1 Issue 3 Pg. no.-  7  
T
a
b
le
 4
. 
T
h
e
 A
U
C
, 
se
n
si
ti
vi
ty
, 
sp
e
ci
fi
ci
ty
, 
p
p
v 
a
n
d
 n
p
v 
o
f 
p
re
o
p
e
ra
ti
ve
 a
n
d
 p
o
st
o
p
e
ra
ti
ve
 N
T
-p
ro
B
N
P
 l
e
ve
ls
 i
n
 t
h
e
 p
re
d
ic
ti
o
n
 o
f 
o
u
tc
o
m
e
s.
 
T
im
e
 p
o
in
t 
o
f 
 
N
T
-p
ro
B
N
P
 
m
e
a
su
re
e
n
t 
P
re
d
ic
te
d
 V
a
ri
a
b
le
 
A
re
a
 u
n
d
e
r 
th
e
 
cu
rv
e
 (
A
U
C
) 
U
si
n
g
 N
T
-p
ro
B
N
P
 c
u
t-
o
ff
 >
 4
0
p
m
o
l/
l 
U
si
n
g
 N
T
-p
ro
B
N
P
 c
u
t-
o
ff
 >
 9
0
p
m
o
l/
l 
se
n
s 
sp
e
c 
p
p
v 
n
p
v 
se
n
s 
sp
e
c 
p
p
v 
n
p
v 
P
re
o
p
e
ra
ti
ve
 
D
e
a
th
 
  
0
.8
3
 
(0
.6
7
3
-0
.9
9
3
) 
7
3
%
 
(4
6
-9
9
) 
8
0
%
 
(7
1
-8
8
) 
3
1
%
 
(1
3
-4
9
) 
9
6
%
 
(9
1
-1
0
0
) 
5
5
%
 
(2
5
-8
4
) 
9
2
%
 
(8
7
-9
8
) 
4
6
%
 
(1
9
-7
3
) 
9
4
%
 
(8
9
-9
9
) 
C
a
rd
ia
c 
d
e
a
th
 
  
0
.9
1
4
 
(0
.8
2
3
-1
.0
0
0
) 
8
0
%
 
(4
5
-1
0
0
) 
7
7
%
 
(6
8
-8
5
) 
1
5
%
 
(2
-2
9
) 
9
9
%
 
(9
6
-1
0
0
) 
8
0
%
 
(4
5
-1
0
0
) 
9
1
%
 
(8
5
-9
6
) 
3
1
%
 
(6
-5
6
) 
9
9
%
 
(9
7
-1
0
0
) 
C
a
rd
ia
c 
C
o
m
p
lic
a
ti
o
n
s 
  
0
.8
7
5
 
(0
.7
5
7
-0
.9
9
3
) 
7
5
%
 
(4
5
-1
0
0
) 
7
8
%
 
(7
0
-8
7
) 
2
3
%
 
(7
-3
9
) 
9
7
%
 
(9
4
-1
0
0
) 
7
5
%
 
(4
5
-1
0
0
) 
9
2
%
 
(8
7
-9
8
) 
4
6
%
 
(1
9
-7
3
) 
9
8
%
 
(9
5
-1
0
0
) 
2
4
h
 p
o
st
o
p
e
ra
ti
ve
 
D
e
a
th
 
  
0
.7
5
4
 
(0
.5
7
5
-0
.9
3
4
) 
9
1
%
 
(7
4
-1
0
0
) 
3
8
%
 
(2
8
-4
8
) 
1
5
%
 
(7
-2
4
) 
9
7
%
 
(9
2
-1
0
0
) 
6
4
%
 
(3
5
-9
2
) 
7
2
%
 
(6
3
-8
1
) 
2
2
%
 
(8
-3
6
) 
9
4
%
 
(8
9
-1
0
0
) 
C
a
rd
ia
c 
d
e
a
th
 
  
0
.8
7
6
 
(0
.6
8
3
-1
.0
0
0
) 
1
0
0
%
 
(1
0
0
-0
0
) 
3
7
%
 
(2
7
-4
7
) 
8
%
 
(1
-1
4
) 
1
0
0
%
 
(1
0
0
-0
0
) 
8
0
%
 
(4
5
-1
0
0
) 
7
1
%
 
(6
1
-8
0
) 
1
3
%
 
(1
-2
4
) 
9
9
%
 
(9
6
-1
0
0
) 
C
a
rd
ia
c 
C
o
m
p
lic
a
ti
o
n
s 
  
0
.8
4
0
 
(0
.6
5
9
-1
.0
0
0
) 
8
8
%
 
(6
5
-1
0
0
) 
3
7
%
 
(2
7
-4
7
) 
1
1
%
 
(3
-1
8
) 
9
7
%
 
(9
2
-1
0
0
) 
7
5
%
 
(4
5
-1
0
0
) 
7
2
%
 
(6
3
-8
1
) 
1
9
%
 
(5
-3
2
) 
9
7
%
 
(9
3
-1
0
0
) 
4
8
h
 p
o
st
o
p
e
ra
ti
ve
 
D
e
a
th
 
  
0
.7
4
8
 
(0
.5
6
0
-0
.9
3
6
) 
9
0
%
 
(7
1
-1
0
0
) 
2
5
%
 
(1
6
-3
4
) 
1
2
%
 
(5
-1
9
) 
9
6
%
 
(8
7
-1
0
0
) 
7
0
%
 
(4
2
-9
8
) 
5
8
%
 
(4
8
-6
8
) 
1
6
%
 
(5
-2
7
) 
9
4
%
 
(8
8
-1
0
0
) 
C
a
rd
ia
c 
d
e
a
th
 
  
0
.9
0
7
 
(0
.8
0
7
-1
.0
0
0
) 
1
0
0
%
 
(1
0
0
-0
0
) 
2
4
%
 
(1
6
-3
3
) 
5
%
 
(0
.2
-1
0
) 
1
0
0
%
 
(1
0
0
-0
0
) 
1
0
0
%
 
(1
0
0
-0
0
) 
5
7
%
 
(4
7
-6
7
) 
9
%
 
(0
.6
-
1
0
0
%
 
(1
0
0
-0
0
) 
C
a
rd
ia
c 
C
o
m
p
lic
a
ti
o
n
s 
  
0
.9
3
9
 
(0
.8
7
6
-0
.9
9
9
) 
1
0
0
%
 
(1
0
0
-0
0
) 
2
5
%
 
(1
6
-3
4
) 
9
%
 
(3
-1
6
) 
1
0
0
%
 
(1
0
0
-0
0
) 
1
0
0
%
 
(1
0
0
-0
0
) 
5
9
%
 
(4
9
-6
9
) 
1
6
%
 
(5
-2
7
) 
1
0
0
%
 
(1
0
0
-0
0
) 
N
u
m
b
e
rs
 i
n
 p
a
re
n
th
e
se
s 
a
re
 9
5
%
 c
o
n
fi
d
e
n
ce
 i
n
te
rv
a
ls
 
 Freely Available  Online 
www.openaccesspub.org  |  JCRC    CC-license             DOI : 10.14302/issn.2471-7061.jcrc-18-2446                    Vol-1 Issue 3 Pg. no.-  8  
undiagnosed leaks, as one previous study demonstrated 
that approximately 40% of patients having cardiac 
symptoms following a restorative colorectal resection, in 
fact had suffered an anastomotic leak.18 
 The NT-proBNP test is safe and convenient, 
requiring only a routine venepuncture. Currently a 
routine NT-proBNP test will cost the NHS £25.00 per 
patient and this is relatively cheap to screen some of the 
high-risk patients. However, there are no data to 
support the use of NT-proBNP in the general screening 
of asymptomatic populations for heart failure prior to 
surgery. What is clear from our study is that NT-proBNP 
measurements are useful as an adjunct to other clinical 
tools to determine the risks of patients undergoing              
non-cardiac surgery. With the current emerging 
evidence, NT-proBNP has the potential to be used in 
clinical practice. Patients with high risks of                 
cardiovascular disease should have a screening                    
NT-proBNP blood test. Patients with elevated NT-proBNP 
should be referred to a cardiologist for consideration of 
additional stress testing or echocardiogram, to assess 
the presence and extent of coronary artery disease. 
Conversely patients with normal NT-proBNP tests have 
the potential to avoid unnecessary patient referral for 
echocardiography or stress testing. 
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